首页> 美国卫生研究院文献>BMC Microbiology >High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE−/− mice
【2h】

High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE−/− mice

机译:高脂饮食引起的动脉粥样硬化伴有结肠菌多样性低和与斑块大小血浆A-FABP和胆固醇相关的丰度变化:高脂饮食及其对鼠李糖乳杆菌GG(LGG)或替米沙坦干预ApoE-的初步研究/-老鼠

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAtherosclerosis appears to have multifactorial causes – microbial component like lipopolysaccharides (LPS) and other pathogen associated molecular patterns may be plausible factors. The gut microbiota is an ample source of such stimulants, and its dependent metabolites and altered gut metagenome has been an established link to atherosclerosis. In this exploratory pilot study, we aimed to elucidate whether microbial intervention with probiotics L. rhamnosus GG (LGG) or pharmaceuticals telmisartan (TLM) could improve atherosclerosis in a gut microbiota associated manner.
机译:背景动脉粥样硬化似乎有多方面的原因-微生物成分,如脂多糖(LPS)和其他与病原体相关的分子模式可能是合理的因素。肠道菌群是这类刺激物的充足来源,其依赖的代谢产物和改变的肠道元基因组已与动脉粥样硬化建立了联系。在这项探索性先导研究中,我们旨在阐明益生菌鼠李糖乳杆菌GG(LGG)或药物替米沙坦(TLM)的微生物干预是否可以通过肠道菌群相关的方式改善动脉粥样硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号